Package 16571-862-50

{"route": ["ORAL"], "spl_id": "a047dcfb-9b8c-446e-815e-2ee800cc7b79", "openfda": {"upc": ["0316571862030", "0316571863037"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["e4f4d3fa-ddf6-4125-8486-8157efc095c1"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-03)", "package_ndc": "16571-862-03", "marketing_start_date": "20220801"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-09)", "package_ndc": "16571-862-09", "marketing_start_date": "20220801"}, {"sample": false, "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-10)", "package_ndc": "16571-862-10", "marketing_start_date": "20220801"}, {"sample": false, "description": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-12)", "package_ndc": "16571-862-12", "marketing_start_date": "20240603"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16571-862-50)", "package_ndc": "16571-862-50", "marketing_start_date": "20220801"}], "brand_name": "bupropion hydrochloride", "product_id": "16571-862_a047dcfb-9b8c-446e-815e-2ee800cc7b79", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "16571-862", "generic_name": "bupropion hydrochloride", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bupropion hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA211020", "marketing_category": "ANDA", "marketing_start_date": "20220801", "listing_expiration_date": "20261231"}